搜索到 1000 条关于 ◐모바일 바다이야기추천㎚raY800.top㎤올쌈바♭바다이야기게임연타┐모바일 무료야마토게임┭릴게임하는법†사이트바다이야기게임 的文章

2012.09.27 第二届全国乳腺癌论坛(南京)

年7月16日全天网上报名:www.jsbreastcancer.com会议费用:会务费(含资料费、学分证费)5月31日前800元,6月1日至

2012.09.19 国际华人脊柱学会(ICSS)成立大会暨首届学术研讨会

深入讨论。本次会议将授予国家级继续教育I类学分,会议注册费每人800元。欢迎全国骨科同仁积极参与。会议详细信息请登录本届会议网站

2012.09.19 中华医学会第八次全国计划生育学术会议参会通知

生为 800 元(凭注册医师证、研究生证件),代表食宿由会议统一安排,费用回单位报销。住宿标准:豪标每天每间 420 元(含双早),普标每天每间

2012.09.19 2012年《临床科研方法与实施》学习班

600元800元 

2012.09.19 2012年《临床科研方法与实施》学习班

在读研究生600元800

2012.09.19 第三期影像技术在关节炎诊治中的应用

、传统X线在RA中的应用8、传统X线在RA中的SHARP评分系统收费:培训费800元(含教材及餐费);住宿费自理(协助

2012.09.19 第八次全国脑电图与癫痫诊治进展高级讲授班及学术研讨会

800~1000字的论文摘要1份。摘要请按目的、方法、结果、结论的结构形式撰写。会议采用Email方式投稿,作者及单位请标注于文题下,文后注明联系电话

2012.09.19 第四届复旦国际神经病学论坛--神经变性疾病的转化医学研究

的学费800元,资料费200元, 食宿代为安排,住宿费用自理,学员可获得国家级继续教育I类学分10分。欢迎广大临床医师和研究人员踊跃报名参加。联系人:复旦大学

2012.09.19 中华医学会超声医学分会第十一次全国超声医学学术会议

论文摘要一份,每篇800-1000字,请务必以目的、方法、结果、结论格式书写摘要内容。2. 参加中青年英语论坛者,只需附格式相同的英文摘要一份。(摘要前请

2012.09.19 中华医学会显微外科学分会首届“中国显微外科青年论坛”

积极参与并讨论。会议期间召开中华医学会显微外科分会全体青年委员会会议。征文要求:⑴论文未公开发表;⑵来搞寄800字以内四段式摘要及全文,并详细注明作者姓名

2012.09.19 海峡两岸品质经营与创新服务管理论坛

,每团限20人)三、费用标准:会务费:800元/人/期,食、宿及交通费用自理。为方便各位院长沟通交流,我们将统一安排食宿,请各位代表提前预订

2012.09.19 第二届全国乳腺癌论坛(南京)

年7月16日全天网上报名:www.jsbreastcancer.com会议费用:会务费(含资料费、学分证费)5月31日前800元,6月1日至

2012.09.19 第十一次全国血液学术会议

://www.csh-cma.org.cn在线投稿系统投稿。本次会议不接受邮寄稿件。3.所投稿件应是未公开发表及未在全国学术会议上交流过的论文,600~800字摘要1份

2012.09.19 2010年全国神经外科麻醉年会

新技术产业园区榕苑路1号 300384)会务费:800元(食宿费自理,会议统一安排)注:为了保证您按时返回,提醒您订购往返机票或车票,谢谢

2012.09.19 国际脊柱创新发展学会第二届亚太学年会(APSAS)

论文摘要。注册费:即日起提前网上注册费一律RMB800元/人,现场注册费1000元/人。注册代表食宿将得到优先安排。

2012.09.19 2010年北京第四届疝和腹壁外科国际学术研讨会

、并发症的防治等方面的稿件在大会上交流,本次大会高质量的论文将安排作者在大会上发言并且在中华疝和腹壁外科杂志(电子版)上陆续刊登。本次会议会务费800元/每人,资料

2012.07.27 第十届全国胃病学术大会

。3.要求:1)未公开发表过,内容科学,数据准确,书写规范,摘要800字内,全文3000字内;2)欢迎特殊、疑难病例讨论投稿

2020.06.17 【直播 | 现场】计算机辅助设计—分子模拟与蛋白互作研讨班(8.20-22)

。【报名回执】访问此链接填写报名回执(https://www.wjx.top/jq/80710449.aspx)【咨询请联系】QQ 号:2814500767邮箱

2012.09.19 2011年生物仿制药会议(Biosimilars Asia 2011)

时间: 2011-5-23 至 2011-5-26
地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

5 Reasons To Attend
  • Only conference in Asia which addresses concerns faced by the Asian biosimilar companies with experts from the region and beyond
  • Learn from and personally meet senior executives from the major stakeholders amongst from biosimilar to innovator companies
  • The most comprehensive event highlighting key challenges in the industry including manufacturing, marketing, pricing, transitioning from generics to biosimilars and regulatory issues
  • Showcasing unique case studies from leading Asian and international biosimilar companies
  • Gather the latest insights from regional biosimilar companies and MNCs about their strategic decisions and how they are positioning themselves for success

Industry Gurus / Speakers
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals

Past Attendees Include
Vice President, ASTRAZENECA INNOVATION CENTER (China)
Senior Director, GENENTECH INC, (USA)
Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore)
Managing Director, ASAHI GLASS CO LTD (Japan)
Deputy General Manager, SINOPHARM (China)
Head, Biotech Research, USV LTD (India)
General Manager, JCR PHARMACEUTICALS CO LTD (Japan)
Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China)
Senior Research Associate, HANWHA CHEMICAL (South Korea)
Vice President, BOEHRINGER INGELHEIM GMBH (Germany)
General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China)
IP Director, HOSPIRA (AUSTRALIA)
President, MYCENAX BIOTECH INC (Taiwan)
Senior Director, MERCK & CO INC (USA)
Associate Director, DR REDDY''''''''S LABORATORIES LTD (India)
Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China)
Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China)
Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China)
General Manager, NIPPON KAYAKU CO LTD (Japan)
President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA)
Vice President, RANBAXY (USA)

Registration

FEES per delegate
Early Bird Rate
Register & Pay before 11 March 2011
Special Rate
Register & Pay before 15 April 2011
Normal Rate
Register & Pay after 15 April 2011
Group Rate
Group of 3 or more
?
US$ / CNY
US$ / CNY
US$ / CNY
US$ / CNY
4 day package
(Conf + Pre & Post Workshops)
2,495 /
16,600
2,695 /
17,950
2,895 /
19,500
2,175 /
14,650
3.5 day package (Conf + Workshop C & A or B )

2,295 /
15,500

2,495 /
16,600
2,695 /
17,950
2,025 /
13,500
3 day package (Conf + Workshop A & B or C)
1,995 /
13,500
2,195 /
14,600
2,395 /
15,950

1,795 /
12,000

2.5 day package (Conf + Workshop A or B)
1,795 /
12,000
1,995 /
13,500
2,195 /
14,600
1,695 /
10,950
2 day package
(Conf only)
1,495 /
9,950
1,695 /
11,300
1,895 /
12,600
1,495 /
9,950

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

  • Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
  • Payment by telegraphic transfer in S$ must be made to:
    IBC Asia (S) Pte Ltd
    A/C No.: 147-059513-001 (SGD)
    The Hongkong and Shanghai Banking Corporation Limited
    21 Collyer Quay, HSBC Building, Singapore 049320
    Bank Swift Code: HSBCSGSG
    Bank Code: 7232
  • Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
  • Payment by telegraphic transfer in CNY must be made to:
    A/C Name:
    A/C No.: 720-031103-001
    Beneficiary Bank:
    Bank Address: No. 1000 Lujiazui Rind Road,
    Pudong, Shanghai 200120, P.R. China
    Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式电话:+65 650 82401
卒中后抗血小板出血风险有多大?有这10个特征需谨慎

2017.08.13 卒中后抗血小板出血风险有多大?有这10个特征需谨慎

)(即 S2TOP-BLEED 评分模型,见表1)。表 1 预测严重出血的S2TOP-BLEED 评分(来自多变量 Cox 回归模型)具体评分方法为,根据患者临床特征评估 S2TOP-BLEED 评分列表中每一栏分值,除了年龄相关的项目外,将其他所有项目分值想加得总分,再将总分代入图 1 所示风险分布图中,得到不同
上一页 1 2 3 ... 43 44 45 ... 48 49 50 下一页 到第